Shandong Sito Bio-technology Co., Ltd. (SZSE: 300583)
Health Care · Pharmaceuticals · CN
CN¥13.70
+1.33% today · -9.4% 1Y
Shandong Sito Bio-technology Co., Ltd. (SZSE: 300583) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $387.45M and employs 990 people.
Over the last twelve months the share price has lost 9.4%, trading between 10.63 and 16.27.
Tweenvest scores Shandong Sito Bio-technology Co., Ltd. across four factors: quality 58/100, value 45/100, growth 3/100, dividend 38/100. Its strongest factor is quality.
300583 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $387.45M
- Revenue (TTM)
- $165.15M
- P/E
- 263.61
- EPS
- 0.05
- Dividend yield
- 0.11%
- Beta (5Y)
- 0.14
- 52-week high
- CN¥16.27
- 52-week low
- CN¥10.63
- Avg volume (3M)
- —
- Shares outstanding
- 189.70M
- Employees
- 990
- Next earnings
- —
About Shandong Sito Bio-technology Co., Ltd.
Shandong Sito Bio-technology Co., Ltd. researches, develops, and produces steroid biomedicine intermediates. Its products include 9a-hydroxyandrost, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, neomycin sulfate, progesterone intermediate, tylvalosin tartrate, tetraene acetate, androstenedione, bisnoralcohol, norandrostenedione, ethylene deltenone, 16ß and 16a methyl epoxide, and hexahydro-3a-methyl, as well as androsta-1,4-diene-3,17-dione and estra-4,9-diene-3,17-dione. Shandong Sito Bio-technology Co., Ltd. was founded in 2002 and is based in Heze, China.
- ISIN
- CNE100002F36
- Founded
- 2002
- Listed since
- Jan 9, 2017
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,LtdSHSE: 600671 | $395.59M | CN¥21.79 | -5.38% |
| Unichem Laboratories LimitedBSE: 506690 | $391.59M | Rs535.50 | -2.67% |
| Foresee Pharmaceuticals Co., Ltd.TPEX: 6576 | $390.70M | NT$79.00 | -1.50% |
| KYORIN Pharmaceutical Co., Ltd.TSE: 4569 | $387.90M | ¥1,065.00 | -6.58% |
| Kwality Pharmaceuticals LimitedBSE: 539997 | $384.99M | Rs3,572.35 | -2.70% |
| Verano Holdings Corp.CNSX: VRNO | $384.70M | CA$7.49 | -11.99% |
| Relmada Therapeutics, Inc.NasdaqCM: RLMD | $384.01M | $3.17 | -11.94% |
| Zhejiang Shengda Bio-Pharm Co., Ltd.SHSE: 603079 | $380.31M | CN¥13.61 | +3.81% |
Figures last refreshed Oct 4, 2026.